 NORCROSS, Ga., Nov. 05, 2021 GLOBE NEWSWIRE -- Galectin Therapeutics Inc. NASDAQ:GALT, the leading developer of therapeutics that target galectin proteins, today announced that it will present six scientific abstracts at The Liver MeetingTM 2021, hosted by the American Association for the Study of Liver Diseases AASLD, to be held virtually from November 12 to 15, 2021. 